VVY (VVY) News
Follow VVY (VVY) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Vivoryon Therapeutics N.V. (VVY) Shareholders Approve All AGM Items, Including CFO Appointment
Vivoryon Therapeutics N.V. said shareholders approved all AGM agenda items, including appointing CFO Marcus Irsfeld and re-appointing Dr. Frank Weber and Dr. Michael Schaeffer as executive directors.Material DetailsConte
NEWS | Sep 29, 2026, 04:02 PM UTC
L
Vivoryon Therapeutics N.V. Reports Outcome of 2026 Annual General Meeting
Vivoryon Therapeutics N.V. Reports Outcomeof 2026 Annual General MeetingHalle (Saale) / Munich, Germany, September 29, 2026 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon), a clinical stag
NEWS | Sep 29, 2026, 04:01 PM UTC